Home / Atovaquone / Belgium
BE ATC P01AX06 · updated 3 Nov 2026
Atovaquone shortage in Belgium
Is there an Atovaquone shortage in Belgium?
Yes. As of 3 Nov 2026, 1 Atovaquone product is reported short in Belgium, the first since 2 Nov 2026. The company estimate for the return is 5 Feb 2027. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Wellvone 750 mg/5 ml or. susp. 226 ml | GlaxoSmithKline Pharmaceuticals | 2 Nov 2026 | 5 Feb 2027 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.